Genoa, a QoL Healthcare Company (Genoa) is pleased to announce the publication of Integrated Pharmacies at Community Mental Health Centers: Medication Adherence and Outcomes” by W. Abel Wright, Jack Gorman, Melissa Odorzynski, Mark Peterson, and Carol Clayton in the Journal of Managed Care & Specialty Pharmacy. For more information, please read the press release HERE.
Genoa Healthcare® pharmacist Julie R. has seen firsthand the impact that severe and persistent mental illness can have on a person. For one of her consumers living with schizophrenia, the...
Tardive Dyskinesia – a neurological disorder linked to prolonged use of antipsychotic medications – impacts over 600,000 individuals each year. Did you know that 50% of consumers taking TD medication...
A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...
Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...